Frost & Sullivan commends Merck Serono for its excellence in product differentiation
Advertisement
Merck Serono announced that based on its recent analysis of the human growth hormones (HGH) market, Frost & Sullivan recognises Merck Serono with the 2013 Europe Product Differentiation Excellence Award.
“Merck Serono is lauded for its cutting-edge drug delivery devices - easypod® and cool.click®2 – that facilitate the simple and effective administration of Saizen®, the recombinant HGH used for the treatment of endogenous growth hormone deficiency in children and adults,” noted Frost & Sullivan Healthcare Senior Research Analyst Aiswariya Chidambaram. “These devices successfully address long standing challenges related to poor patient compliance and low adherence to HGH therapy.”